MarketInOut Stock Screener Log In | Sign Up
 

10x Genomics Inc

NASDAQ • Healthcare • Health Information Services • Quote as of 05/22/2026
10x Genomics Inc stock price and volume chart

Company Profile

IndustryHealth Information Services
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,041.87 mln
Float115 mln
Earnings Date08/06/2026

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.97
Likely reliable

1-Year Forecast

25.23
Modest upside

Relative Strength

91 / 100
Top performer

Debt / Equity

0.10
Very low leverage

ROE

-2.92
Negative

Business Description

10x Genomics, headquartered in Pleasanton, California, makes tools that help scientists study the biology of individual cells and tissues. The company sells laboratory instruments, consumables, and software to universities, government agencies, and pharmaceutical and biotech companies across North America, Europe, the Middle East, Africa, China, and the Asia Pacific region. Its products allow researchers to examine where and how genes are active within cells and tissue samples, generating insights that support advances in medicine and life sciences.

Key Fundamentals

EPS-0.17
ROE-2.92
RPS5.07
ROIC-17.07
ROA-2.28
EBITDA, mln85.06
EV / EBITDA30.93
EV / EBIT67.20
Revenue, mln639
EV / Revenue4.12

Financial Strength

Altman Z-Score5.55
Piotroski F-Score 6 / 9
Beneish M-Score-2.97
1-Year Target Price25.23
Short Ratio6.57
Short % of Float19.00

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 11.7% 93 / 100   
1 Month 10.55% 85 / 100   
2 Months 30.68% 89 / 100   
6 Months 51.31% 91 / 100   
1 Year 185% 95 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us